Vertex Pharmaceuticals (NQ:VRTX)

These are great picks with or without soaring inflation.

Topics Intellectual Property

Inflation-Proof Investing: Which Growth Stock Will Double Your Money in 6 Years? ↗

November 03, 2025

This stock isn't bulletproof. But it should be a big winner over the coming years.

Topics Economy Government World Trade

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

My Top Growth Stock to Buy in November ↗

November 02, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be announcing earnings results this Monday after market hours. Here’s what you need to know.

Vertex Pharmaceuticals (VRTX) Q3 Earnings: What To Expect

November 01, 2025

Via StockStory

How Royalty Pharma Prints Cash Without Biotech's Biggest Risks ↗

October 31, 2025

Via MarketBeat

Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today ↗

October 30, 2025

Via Benzinga

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Fundamentals and Bullish Technical Setup ↗

October 29, 2025

Discover how Vertex Pharmaceuticals (VRTX) combines strong fundamentals, like high profitability and no debt, with a bullish technical breakout pattern for potential growth.

Via Chartmill

If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These ↗

October 28, 2025

These two have been neglected by Wall Street too much.

Vertex to Participate in the UBS Global Healthcare Conference on November 11

October 27, 2025

Vertex appears to be by far the better buy right now.

Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030 ↗

October 27, 2025

There's no guarantee that any stock will deliver positive returns. But the odds look good for these three.

Topics Intellectual Property

The Best Stocks to Invest $50,000 In Right Now ↗

October 24, 2025

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference

Topics Artificial Intelligence Energy

October 23, 2025

Vertex Pharmaceuticals (VRTX) presents a value investing case with strong profitability, a debt-free balance sheet, and a valuation that appears attractive relative to its industry peers.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A Value Investment Case Study ↗

October 20, 2025

Via Chartmill

2 Growth Stocks to Invest $1,000 in Right Now ↗

October 19, 2025

These companies have a habit of beating the market, and they are far from having peaked.

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week

Topics Artificial Intelligence World Trade

October 17, 2025

These companies' market-beating fuel hasn't run out yet.

2 Soaring Cathie Wood Stocks to Buy and Hold ↗

October 17, 2025

Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market ↗

October 16, 2025

Bank of America initiates coverage on Vera Therapeutics, citing strong potential for atacicept, its kidney treatment.

Via Benzinga

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Offers Affordable Growth in Biotech ↗

October 15, 2025

Vertex Pharmaceuticals (VRTX) offers strong growth, solid earnings, and a robust financial position, all at a reasonable price compared to biotech peers.

Via Chartmill

2 Unstoppable Growth Stocks to Buy During a Market Crash ↗

October 15, 2025

Here are two smart ways to prepare for the next market downturn.

Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today ↗

Topics Government Stocks World Trade

October 14, 2025

Via Benzinga

4 Healthcare Stocks to Buy Now ↗

October 12, 2025

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.

Vertex isn't your run-of-the-mill biotech stock.

Topics Artificial Intelligence

Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity ↗

October 08, 2025

Via Benzinga

The Smartest Growth Stock to Buy With $500 Right Now ↗

October 08, 2025

Over the past six months, Vertex Pharmaceuticals’s stock price fell to $413.23. Shareholders have lost 12.5% of their capital, which is disappointing considering the S&P 500 has climbed by 34.7%. This...

Topics Economy

Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q2 Earnings?

October 08, 2025

Via StockStory

Topics Stocks

Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500 ↗

October 07, 2025

Tariffs aren't likely to weigh on growth at these companies.

Topics Government Stocks World Trade

Vertex to Announce Third Quarter 2025 Financial Results on November 3rd

October 06, 2025

Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years ↗

October 06, 2025

Via Benzinga

1 Healthcare Stock with Exciting Potential and 2 Facing Challenges

October 06, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

2 Beaten-Down Stocks Primed for a Comeback ↗

October 05, 2025

The market is sleeping on these stocks, but you don't have to.